Frontiers in Oncology | Hematologic Malignancies

Perspective

Published on 01 Dec 2022

Should we adopt an automated de-centralized model of chimeric antigen receptor- T cells manufacturing for low-and middle-income countries? A real world perspective

in Hematologic Malignancies

Sharanya Ramakrishnan
Jeevan Kumar
Suvro Sankha Datta
Vivek Radhakrishnan
Reena Nair
Mammen Chandy

Frontiers in Oncology

doi 10.3389/fonc.2022.1062296

3,781 views
6 citations

Original Research

Published on 01 Dec 2022

Cerebrospinal fluid interleukin-6 is a potential diagnostic biomarker for central nervous system involvement in adult acute myeloid leukemia

in Hematologic Malignancies

Jiayan Gu
Xin Huang
Yi Zhang
Chenhui Bao
Ziyang Zhou
Hongyan Tong
Jie Jin

Frontiers in Oncology

doi 10.3389/fonc.2022.1013781

2,925 views
5 citations

Original Research

Published on 01 Dec 2022

Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines

in Hematologic Malignancies

Rafael Renatino Canevarolo
Carolina Pereira de Souza Melo
Nathalia Moreno Cury
Leonardo Luiz Artico
Juliana Ronchi Corrêa
Yanca Tonhasca Lau
Samara Sousa Mariano
Praneeth Reddy Sudalagunta
Silvia Regina Brandalise
Ana Carolina de Mattos Zeri

Frontiers in Oncology

doi 10.3389/fonc.2022.1032336

10,354 views
9 citations

Original Research

Published on 01 Dec 2022

CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)

in Hematologic Malignancies

Yuan Jian
Zhiyao Zhang
Huixing Zhou
Guangzhong Yang
Chuanying Geng
Huijuan Wang
Wen Gao
Wenming Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1061438

5,914 views
7 citations

Review

Published on 30 Nov 2022

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

in Hematologic Malignancies

Enrico Maffini
Margherita Ursi
Francesco Barbato
Michele Dicataldo
Marcello Roberto
Elena Campanini
Elisa Dan
Francesco De Felice
Serena De Matteis
Gianluca Storci

Frontiers in Oncology

doi 10.3389/fonc.2022.1066285

4,440 views
6 citations

Brief Research Report

Published on 30 Nov 2022

Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?

in Hematologic Malignancies

Maria Cruz Cárdenas
Belén Iñigo
Isabel Ortega
Maria Angeles Palomar
Marina Menéndez
Paula Plaza
Mercedes Martínez-Novillo
Celina Benavente

Frontiers in Oncology

doi 10.3389/fonc.2022.1056293

6,188 views
3 citations

Original Research

Published on 29 Nov 2022

Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines

in Hematologic Malignancies

Mariaserena Giliberto
Leonardo Miranda Santana
Toril Holien
Kristine Misund
Sigve Nakken
Daniel Vodak
Eivind Hovig
Leonardo A. Meza-Zepeda
Eivind Coward
Anders Waage

Frontiers in Oncology

doi 10.3389/fonc.2022.1040730

4,144 views
5 citations

Original Research

Published on 29 Nov 2022

The use of carbon monoxide breath test to detect the effect of iron overload on erythrocyte lifespan in MDS

in Hematologic Malignancies

Yao Zhang
Yan Qian
Lu-xi Song
Chao Xiao
Chun-kang Chang

Frontiers in Oncology

doi 10.3389/fonc.2022.1058482

2,628 views
6 citations

Case Report

Published on 29 Nov 2022

Case report: Plasmablastic neoplasm with multinucleated giant cells—Analysis of stemness of the neoplastic multinucleated giant cells

in Hematologic Malignancies

Narumi Otsuka-Kamakura
Yoshiya Sugiura
Toshiki Yamazaki
Naomi Shimizu
Nobuyuki Hiruta

Frontiers in Oncology

doi 10.3389/fonc.2022.1023785

3,216 views
2 citations

Original Research

Published on 28 Nov 2022

Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia

in Hematologic Malignancies

Fang-Min Zhong
Fang-Yi Yao
Jing Liu
Hai-Bin Zhang
Jing Zhang
Nan Zhang
Jin Lin
Shu-Qi Li
Mei-Yong Li
Jun-Yao Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.888570

6,160 views
17 citations

Mini Review

Published on 28 Nov 2022

“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow

in Hematologic Malignancies

Paola Pacelli
Donatella Raspadori
Elena Bestoso
Alessandro Gozzetti
Monica Bocchia

Frontiers in Oncology

doi 10.3389/fonc.2022.1057713

5,212 views
3 citations

Systematic Review

Published on 28 Nov 2022

Impact of mutations in epigenetic modifiers in acute myeloid leukemia: A systematic review and meta-analysis

in Hematologic Malignancies

Fatma Al-Bulushi
Rahma Al-Riyami
Zainab Al-Housni
Bushra Al-Abri
Murtadha Al-Khabori

Frontiers in Oncology

doi 10.3389/fonc.2022.967657

3,727 views
4 citations

Review

Published on 25 Nov 2022

Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies

in Hematologic Malignancies

Masamitsu Yanada
Kaito Harada
Yoshimitsu Shimomura
Yasuyuki Arai
Takaaki Konuma

Frontiers in Oncology

doi 10.3389/fonc.2022.1050633

9,188 views
11 citations

Case Report

Published on 25 Nov 2022

Multiple myeloma with isolated central nervous system relapse after autologous stem cell transplantation: A case report and review of the literature

in Hematologic Malignancies

Xian Li
Weiqin Wang
Xiaohong Zhang
Yun Liang

Frontiers in Oncology

doi 10.3389/fonc.2022.1027585

3,705 views
4 citations

Review

Published on 24 Nov 2022

Innovation in BCMA CAR-T therapy: Building beyond the Model T

in Hematologic Malignancies

Rahul Banerjee
Sarah S. Lee
Andrew J. Cowan

Frontiers in Oncology

doi 10.3389/fonc.2022.1070353

10,515 views
11 citations

Case Report

Published on 24 Nov 2022

Anti-CD19 chimeric antigen receptor T-cell followed by interferon−α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report

in Hematologic Malignancies

Jing Ni
Junjie Zhou
Zhangbiao Long
Xin Chen
Xiaowen Chen
Jian Hong
Xinglin Liang
Qingsheng Li
Ruixiang Xia
Jian Ge

Frontiers in Oncology

doi 10.3389/fonc.2022.1021786

2,431 views

Original Research

Published on 24 Nov 2022

Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN)

in Hematologic Malignancies

Clàudia Pla
Marta Solans
Alberto Ameijide
Arantza Sanvisens
Marià Carulla
María Dolores Rojas
María Araceli Alemán
Isabel Sáez-Lloret
Cristina Díaz-del-Campo
Ana Isabel Marcos-Navarro

Frontiers in Oncology

doi 10.3389/fonc.2022.1046307

6,987 views
6 citations

Mini Review

Published on 24 Nov 2022

Advances in the understanding and treatment of Cutaneous T-cell Lymphoma

in Hematologic Malignancies

Farrah S. Bakr
Sean J. Whittaker

Frontiers in Oncology

doi 10.3389/fonc.2022.1043254

5,403 views
9 citations

Original Research

Published on 24 Nov 2022

In vivo modelling of cutaneous T-cell lymphoma: The role of SOCS1

in Hematologic Malignancies

Yixin Luo
Maarten H. Vermeer
Frank R. de Gruijl
Willem H. Zoutman
Marjolein Sluijter
Thorbald van Hall
Cornelis P. Tensen

Frontiers in Oncology

doi 10.3389/fonc.2022.1031052

4,229 views
5 citations

Original Research

Published on 24 Nov 2022

The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients

in Hematologic Malignancies

Sara Villar
Beñat Ariceta
Xabier Agirre
Aura Daniela Urribarri
Rosa Ayala
David Martínez-Cuadrón
Juan Miguel Bergua
Susana Vives
Lorenzo Algarra
Mar Tormo

Frontiers in Oncology

doi 10.3389/fonc.2022.1054458

3,971 views
7 citations

Original Research

Published on 23 Nov 2022

Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients

in Hematologic Malignancies

Ge Yan
Huangmin Li
Yiding Zhang
Chenyan Xia
Mengxiao Wang
Yu Jia
Jin Shang
Zhanzheng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.1012889

3,555 views
14 citations

Original Research

Published on 23 Nov 2022

A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment

in Hematologic Malignancies

Ja Min Byun
Ho Young Kim
Seung-Hyun Nam
Ho-Jin Shin
Seulki Song
Jinny Park
Sang Hoon Han
Yong Park
Young Jin Yuh
Yeung-Chul Mun

Frontiers in Oncology

doi 10.3389/fonc.2022.989984

4,523 views
4 citations

Case Report

Published on 22 Nov 2022

Case report: Double L611S/V617L JAK2 mutation in a patient with polycythemia vera originally diagnosed with essential thrombocythemia

in Hematologic Malignancies

Xiao-qing Li
Jia-jun Liu
Cheng-cheng Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.937362

2,861 views
1 citation

Original Research

Published on 21 Nov 2022

Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study

in Hematologic Malignancies

Xin-Yu Zhuang
Zheng-Tai Sun
Yue Xu
Ya-Ru Ren
Ying-Jie Chen
Feng Chen
Xiao Ma
Xiao-Wen Tang
Xiao-Feng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1040679

2,060 views
1 citation

2,058 articles

articles

Should we adopt an automated de-centralized model of chimeric antigen receptor- T cells manufacturing for low-and middle-income countries? A real world perspective

Cerebrospinal fluid interleukin-6 is a potential diagnostic biomarker for central nervous system involvement in adult acute myeloid leukemia

Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines

CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?

Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines

The use of carbon monoxide breath test to detect the effect of iron overload on erythrocyte lifespan in MDS

Case report: Plasmablastic neoplasm with multinucleated giant cells—Analysis of stemness of the neoplastic multinucleated giant cells

Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia

“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow

Impact of mutations in epigenetic modifiers in acute myeloid leukemia: A systematic review and meta-analysis

Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies

Multiple myeloma with isolated central nervous system relapse after autologous stem cell transplantation: A case report and review of the literature

Innovation in BCMA CAR-T therapy: Building beyond the Model T

Anti-CD19 chimeric antigen receptor T-cell followed by interferon−α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report

Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN)

Advances in the understanding and treatment of Cutaneous T-cell Lymphoma

In vivo modelling of cutaneous T-cell lymphoma: The role of SOCS1

The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients

Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients

A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment

Case report: Double L611S/V617L JAK2 mutation in a patient with polycythemia vera originally diagnosed with essential thrombocythemia

Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study